In response to Merck’s lawsuit concerning the Inflation Reduction Act’s allowance for the U.S. to negotiate drug prices for the nation’s 10 most expensive medications, the White House said it is “confident we will succeed.”
Read the full post on Becker's Hospital Review - Healthcare News
